Overview

Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The study of safety of ZIO-201-T in combination with doxorubicin in the treatment of advanced cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Ziopharm
Treatments:
Doxorubicin
Ifosfamide
Liposomal doxorubicin